1. Medtech Insight

Abbott Gains FDA Clearance For Lab-Based Concussion Test

 
• By Marion Webb

Abbott said it received the US FDA nod to run its blood-based test to assess patients for concussions on its Alinity i laboratory instrument. This will make the test more widely available in hospitals and laboratories in the US.

Alinity i Laboratory instrument
• Source: Abbott

Abbott announced on 7 March it received US Food and Drug Administration clearance for a laboratory-based blood test used in hospitals to help clinicians assess mild traumatic brain injuries (TBI) in about 18 minutes.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation